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ABSTRACT
Objective: To better understand physicians’ views on
factors of inﬂuence for the prescribing of antibiotics
and on antibiotic resistance in the Berlin region,
Germany.
Design: Qualitative study with focus groups.
Setting: Outpatient care and hospital care practice in
the Berlin region, Germany.
Participants: 7 General practitioners, two urologists,
one paediatrician from outpatient care and eight
internists, two paediatricians, two ear, nose and throat
specialists and two urologists from hospital care.
Results: Physicians showed differential interest in
topics related to antibiotic prescribing and antibiotic
resistance. Outpatient care physicians were interested
in topics around their own prescribing, such as being
able to diagnose and prescribe precisely, and topics
about patient demand and non-compliance. Hospital
care physicians were interested in hygiene challenges,
limited consult time and multi-resistant pathogens.
Conclusions: Physicians considered the development
of resistance to be more in the domain of clinical
treatment than that of the patient. Major challenges
related to antibiotic resistance for this group of
physicians are access to and clarity of treatment
recommendations, implementation of hygienic
measures, as well as increased outsourcing of
laboratory services. Results raise questions about
whether meeting physicians’ expectations should be
a focus when developing intervention that aims to
inﬂuence antibiotic resistance in this and other areas of
Germany.
INTRODUCTION
Antimicrobial use has remained a major
concern in medicine and epidemiology over
the last years. Surveillance initiatives have
been implemented in order to monitor
antimicrobial consumption and usage
patterns and resistance data for selected
pathogens in order to present trends over
time and comparisons between countries and
regions.
1 2 The results provide evidence that
antimicrobial resistance has continued to
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ARTICLE SUMMARY
Article focus
- Overuse of antibiotics across many specialities
and in some of the most common diagnoses
remains a driving force for antibiotic resistance.
- While much attention has focused on limiting use
and addressing clinical concerns like improving
point-of-care diagnostic tests, prior literature has
largely left out the consideration of socio-
behavioural factors that inﬂuence physicians’
decisions to prescribe antibiotics.
- Focus group discussions were used to show
physicians’ views on factors that inﬂuence
their prescribing of antibiotics and antibiotic
resistance.
Key messages
- Berlin area physicians are interested in receiving
help to make informed decisions on the appro-
priate measures for mitigating patient discomfort
and risk.
- In this group, well-informed prescribing practice
appears to be inﬂuenced by non-patient-oriented
factors that are both structural (eg, overcrowding
in hospitals) as well as non-structural in nature
(eg, access to feedback from microbiologists or
time allowed for patient consult).
- Physicians desire intervention activities that
address their own skills, like assessment of
patient needs, time management for consult and
navigation of pharmaceutical consulting.
Strengths and limitations of this study
- Modern methodologies for focus group data
analysis, including a comprehensive plan for
ensuring validity in data-making and data
reduction were used in the study.
- Presented study methodology allows replication
by other research groups.
- The number of participating physicians was
limited; however, they were recruited from
diverse backgrounds with respect to age, sex,
size of practice, care setting and number of years
in practice.
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Open Access Researchpersist across all specialities and in some of the most
common diagnoses. Efforts to combat resistance have
focused on limiting antimicrobial use, providing patient
education about appropriate use and developing better
point-of-care tests. There are also other socio-behav-
ioural factors of antibiotic use and resistance, which
should also be a core part of campaigns that attempt to
monitor resistance in both hospital and outpatient care
settings.
3e6
In 2007, the Robert Koch Institute, the federal public
health institution in Germany, initiated a number of
different studies to investigate factors to be considered
when designing a national strategy to prevent the spread
of antimicrobial resistance. The aim was to use different
methodological approaches to describe factors of inﬂu-
ence for antibiotic prescribing and antibiotic resistance
in Germany. As a preliminary study, a literature review
was conducted to identify previous work on factors
of inﬂuence for antimicrobial prescribing and to guide
further research. The aim of this study using focus
groups was to elicit physicians’ views on factors
that inﬂuence their prescribing of antibiotics and anti-
biotic resistance. As a mixed-methods research approach
can help to explore research ﬁndings in greater detail,
7 8
a further aim was to generate exploratory information
as the basis to develop a nationally representative
cross-sectional survey on the same topic, conducted in
2008.
9
METHODS
Focus group conceptual structure
A conceptual structure was created to serve as the basis
for the focus group discussions. Five conceptual areas
encompassed inﬂuence factors for the following: (1)
general impressions of antibiotic resistance (eg, How is
the development of antibiotic-resistance perceived? How
generally relevant is the topic of rising antibiotic resis-
tance?), (2) prescribing in outpatient care (eg, Which
inﬂuence factors are relevant for prescribing antibiotics?
Which factors are relevant for prescribing in outpatient
care?), (3) Prescribing in hospital care (eg, Which
inﬂuence factors are relevant for prescribing antibiotics?
Which factors are relevant for prescribing in hospital
care?), (4) Information and knowledge about antibiotic
treatment (eg, what are sources of knowledge about
antibiotics? How are physicians generally informed
about medical areas related to antibiotics?) and (5)
Impressions on problematic areas of concern (eg, How
are problem areas in antibiotics and antibiotic resistance
addressed? Which factors should be addressed by
potential interventions to combat antibiotic resistance?).
Focus group participants
We recruited physicians from the Berlin region,
Germany, with diverse backgrounds with respect to age,
sex, specialty, practice type, the number of patients seen
quarterly and location of practice. Physicians were
offered monetary compensation of V200. We conducted
four focus group sessions of ﬁve to seven physicians
each: (1) outpatient setting, less experience; (2) outpa-
tient setting, more experience and (3) hospital setting,
less experience; (4) hospital setting, more experience
(tables 1 and 2). A qualitative research agency drew the
sample of physicians, and moderated and transcribed all
focus group discussion sessions.
10
Interview methodology
The focus groups were held between 4 and 6 December
2007 in Berlin and were facilitated in four sessions of 2 h
each. All sessions were held separately and conducted by
a trained moderator. Moderators used a semistructured
framework, a method which has been found to enable
participants to share and conﬁrm their views, or
construct new views based on interactions in a peer
Table 1 Focus group participant details: outpatient care
Focus
group
Participant
ID Sex Age Specialty
Practice
type
Years
in practice Location
Patients
per quarter
1 1 Female 46 Paediatrics Group 12 East w900
2 Female 35 General
practitioner
Group 5 West w200
3 Male 48 General
practitioner
Single 9 East w1000
4 Male 54 Urology Single 11 West w1200
5 Male 40 General
practitioner
Group 10 West w800
2 1 Male 62 General
practitioner
Group 25 West w2000
2 Female 53 Urology Group 15 West w800e900
3 Female 55 General
practitioner
Group 16 East w150
4 Female 42 General
practitioner
Group 15 East w180
5 Male 57 General
practitioner
Single 15 East w800e900
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Physicians’ views on antibiotic prescribing and resistancecontext, and build knowledge together.
11 For each
discussion, the framework was based on the topics from
the ﬁve conceptual areas but allowed participants in
each group to explore topics differentially. Interviews
were transcribed in real time, and each session was video
recorded for later in-depth review. To check for accuracy
of the text in each transcription, six random samples of
5e7 min were chosen from the video footage of each
focus group and then checked against the corre-
sponding text. Video footage was also later reviewed in
greater detail in order to explore group dynamics.
Data analysis
A semiquantitative approach was used to analyse the
results of the focus group discussions. This ﬁrst consisted
of examining the data based on the ﬁve conceptual
areas and the respective study questions. We were able to
draw key relationships between conceptual areas, so
called ‘code-categories’ under which were assigned
individual topics arising from the content of the
focus group discussions. The resulting framework was
used to guide all subsequent data-making and analysis
tasks.
A preanalysis code map was developed from the
framework, showing a hierarchy from the ﬁve code cate-
gories to each topic and subtopic. (online supplementary
data table) The code map was then created, to be used
later for constant comparative analysisdan iterative
method of content analysis where each category is
searched and constantly revised, popularly used to allow
so called ‘emergent codes’ to be applied at all points in
the analysis.
12 13 Before beginning the analysis, we vali-
dated our code map by performing a code check,
looking for duplicates and comparing codes to the topics
within the aforementioned framework. Revisions were
made and a resulting code map was used for subsequent
data-making (ﬁgure 1).
All text from transcripts was subjected to constant
comparative analysis, and the frequencies of codes were
used as a measure of signiﬁcance. All data-making and
content analyses were done using TAMS Analyser for
Macintosh OS X (version 4.13), an open-source
computer-assisted qualitative research tool.
14
We extracted quotes from all transcripts when
a speciﬁc topic involved multiple sentences, when the
comment provided was observed to be provocative and/
or when it generated lively discussion among more than
two individuals. We extracted relevant quotes from each
focus group interview in order to further establish an in-
depth look at each topic. An epidemiologist who is
ﬂuent in German and a native English speaker
completed GermaneEnglish translations. We assigned
each participant a quote identiﬁer based on the focus
group in which they belonged and their demographic
information (shown in tables 1 and 2). The identiﬁer is
presented in the Results section as a two numbers (focus
group numberdID number).
RESULTS
Table 3 provides a detailed overview of the highest
incident emergent codes and code categories from
constant comparison analysis for all focus groups
combined. Emergent codes served as a way to begin
further critical analysis of the main insights reﬂected in
this group of physicians, which we present in the
following segments stratiﬁed by each focus group.
Additional in-depth responses on several determinants
of antibiotic prescribing and antibiotic resistance that
cut across all focus groups, such as non-patient factors,
hygiene, the pharmaceutical industry and antibiotic
costs are also presented (table 4).
Focus group 1: outpatient care physicians with fewer years
of practice experience
Physicians focused on themes that are related to
prescribing in the outpatient care setting (frequency:
146). Discussion focused on general impressions of
rising resistance (115), sources of information on
Table 2 Focus group participant details: hospital care
Focus
group
Participant
ID Sex Age Specialty/position
Beds
(n)
Years
in practice Location
Patients
per quarter
3 1 Female 40 Paediatrics/consultant 1200 8 West w600e700
2 Male 34 Internal/resident 620 5 West w400
3 Male 43 Internal/consultant 538 9 East w500
4 Male 42 Internal/resident 626 4 West w300e400
5 Female 34 Internal/resident 363 3.5 West w400
6 Male 30 ENT/resident 1200 3 East w350
7 Male 43 Urology/consultant 220 12 West w500
4 1 Male 51 Internal/consultant 538 16 West w500
2 Female 40 Internal/consultant 1200 14 East w1000
3 Male 56 Internal/consultant 276 31 West w500
4 Male 48 ENT/consultant 1000 10 West w1400
5 Male 41 Internal/consultant 1200 10 West w1000
6 Male 44 Paediatrics/consultant 542 16 West w300e500
7 Female 63 Urology/consultant 1200 37 East w4000
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Physicians’ views on antibiotic prescribing and resistanceantibiotics (64) and physician-oriented interventions
(17). They expressed concern about difﬁculties dealing
with complicated patient histories (12), patient compli-
ance (9) and patient perception of treatment (8).
Participants frequently discussed the development of
antibiotic substances (11) and about responsibility in
their own practice (4). Participants also focused on
speciﬁc diagnoses that are perceived to be driving resis-
tance, with major discussion occurring around the topic
of uncomplicated urinary tract infections (UTIs) (5).
Cost was also discussed as a factor inﬂuencing antimi-
crobial prescribing, speciﬁcally, the effects of health
regulations on the accessibility of medications.
Conferences (9) and pharmaceutical companies (4)
were discussed most when it came to common sources of
information on antibiotics. A large amount of time was
spent discussing pharmaceutical representatives, whom
participants found to be persistent and aggressive:
“They come often and always have antibiotics on hand.
You get a bag of them every day. And high doses of drugs.
It all stacks up in the cabinet. For me there are 4 to 5
representatives each day” (Participant 1e3: tables 1 and 2).
“I notice that they approach me, too. But I do not accept
them all. I would estimate that there are about 5e7 every
day, and they do bring whole bags full (of giveaways).”
(1-2)
“The representatives come into my practice. And you do
listen to them. You even take the information they offer,
even if with a critical eye. But you do learn something as
well.” (1-5)
Figure 1 Plan for data-making,
data reduction and analysis.
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Physicians’ views on antibiotic prescribing and resistance“The pharmaceutical industry is very aggressive.” (1-3)
“For urology I cannot remember in recent months
receiving a visit on this issue. But that is certainly very
different than in the primary care sector.” (1-4)
There was no single participant dominating the
discussion, and comments readily came from each;
however, the paediatrician did mention that there is
less pharmaceutical presence in her practice. This
group most frequently saw feedback on their
resistance situation and cooperation with laboratories
(5) as ways to address the problem of rising antibiotic
resistance.
Focus group 2: outpatient care physicians with more years of
practice experience
Unlike the ﬁrst outpatient group, this group veered away
from a dominant focus on outpatient-speciﬁc topics and
discussed most frequently those topics within the cate-
gory of general impressions on rising resistance (150).
The group was also concerned with having adequate
sources of information on antibiotics (126), outpatient-
speciﬁc inﬂuences on prescribing (105) and other
physician-oriented interventions (28).
Physicians frequently discussed the effectiveness of
antibiotic substances and drug development (6). As in
the previous outpatient care group, cost was seen as
a factor of inﬂuence on antimicrobial prescribing. In this
group, participants agreed that they are less wary of the
cost of antibiotics because the nature of predominantly
short treatments makes it affordable compared with
longer-term treatments, like those prescribed for high
blood pressure. This group also talked about social
factors that may be driving the situation, like increased
foreign travel (6), over-the-counter availability of drugs
abroad (4) and migration (4). The topic of UTIs arose as
a speciﬁc concern driving resistance.
This group discussed the category of hospital-speciﬁc
inﬂuences on prescribing (8), like multi-resistant path-
ogens (6). The topic of hospital hygiene arose in each
of the two outpatient focus groups, which agreed that
antibiotic resistance was largely a problem of the
hospital setting, “In hospitals resistance plays a bigger
role because there one ﬁnds hospital speciﬁc germs.”
(1e4) Incidentally, the topic of resistance was often
quickly averted when brought up, instead being
commented as a problem speciﬁc to the hospital care
setting:
Table 3 Top ﬁve highest incident emergent codes and categories from constant comparison analysis (all groups combined;
total codes n¼1035)
Code-category Five most frequent code topics Frequency
General impressions on rising resistance 401
Patient non-compliance 15
Antibiotics development 13
Hospital-speciﬁc issues, eg, hygiene, laboratories 11
Antibiotic dosing 10
Urinary tract infections 10
Outpatient-speciﬁc inﬂuences on prescribing 251
Patient history 18
Patient demand 18
Physician experience 14
Patient self-education 11
Patient compliance 11
Sources of information on antibiotics 234
Practice guidelines 10
Continuing medical education 8
Specialty journals 8
Internet 8
Quality of conferences 7
Physician-oriented interventions 84
Surveillance 9
Laboratory feedback 7
Information on local resistance situation 7
Hospital 4
Hygiene 4
Hospital-speciﬁc inﬂuences on prescribing 65
Up-to-date internal guidelines 4
Laboratory/microbiologists exchange 4
Speciﬁcity of internal guidelines 4
Experience with infectious diseases 3
Problematic diagnoses 3
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Physicians’ views on antibiotic prescribing and resistanceTable 4 Selected in-depth responses from focus group discussions
Category Quotes
Hygiene Have a look what is happening in the operating rooms. Time for cleaning up is getting shorter every day.
Before we had around 100 beds in a normal ward, now its cut down to 40e50 beds, but we are still treating as
many patients as they were 10 years ago. Get in and get out. A bed is never empty. And I have my doubts as to
whether these disinfectant wipes are an ideal solution. I think the time pressure is there and already a problem. (4-7).
The highest infection rates are in intensive care units, but it is certainly always clean. In the OR smears are
made at regular intervals. I think this is still the safest. Unless they have very septic cases and those cases
where the pus runs from the abdomen. On the hospital ward that is where I think it is not very hygienic. In
intensive care so they can get almost all antibiotics, and that is where the transmission of nosocomial
infections at the highest, and where there are more immunosuppressed patients. (4-1)
From our end in the clinic, it is the hospital-acquired infections that are acquired in the hospital and last for
2e3 days, possibly even later. They are often preventable through effective hygiene measures and can be
much better than they would be with antibiotics. (4-3)
Laboratory
and resistance
data
Our laboratory is outsourced, but once we had also invited a microbiologist to provide training, and he made
a comparison of the germs in hospital with those generally presented in the other hospitals. It was good
information. (4-3)
Many things change as well over the years, procedures change. Too often, there is a deﬁcit in this information.
(4-3)
Guidelines vary and are speciﬁc to each hospital. We have a very committed leader in this area, who takes
a lot of trouble to log and actually follow information from each recommending commission, which often revise
their information. We have a commission that discusses and revises information which is then put online for
reference and so that all staff can gain insight. We also have disclosure on which department prescribe show
much and how expensive it is. This is useful in individual cases, and to follow the development of resistance
and hygiene. So, it is all kept very transparent. (3-3)
Pharmaceutical
industry
Pharmaceutical advertising is very important. There are at least two variants. There are those that visually
present with more or less exciting images and colours. And these accordingly make you curious so that you
might read some ﬁne print and look more closely to ﬁnd out what the stuff is. I ﬁnd this to be the more pleasant
variant. Because you immediately recognize it as such and may or may have to look closer. Medical journals
on the other hand may contain interesting content, but there it’s hard for you to determine what the content is.
Is it a short conference report? Is it a topic that interests me? A professor on a topic I am interested in? Is it
really is objective? And that’s the annoying thing, because then it is difﬁcult to distinguish. (3-7)
They also know as who is receptive. Then they just leave the bag there and just want a signature and a seal.
Much is given at each and every day, many just want a short word. I’ve been doing this at the reception
counter. Very
rarely do I give them an appointment. For me there are 4 to 5 representatives each day. (1-1)
Pharmaceutical representatives give me bags full (of antibiotic samples)! (1-1)
In the moment when the pressure in the outpatient setting is relatively high, even from marketing, then certain
things are pushed. Something has changed in prescribing in the outpatient setting; this is what will notice from
practice in the clinic. Prescribing practice, what is underlying it, this is often not transparent. (4-6)
Cost Until three years ago, I was still prescribing Cotrim in the urology setting. It was still cheap, at about V3. Back
then, gyrase-inhibitors had a starting price of about V12. Then health regulations led to compulsory levies,
which introduced a ﬁxed fee of V8. Since then, Cotrim increased from V3t oV12dthe same as the
gyrase-inhibitors. Until then, the threshold for prescribing gyrase-inhibitors for UTIs was relatively high, and
I prefered to prescribe Cotrim. But since the price drop, I prescribe Cotrim less and more quickly look to
prescribing gyrase-inhibitors. (1-4)
Yes, I would think that costs are different for antibiotics than for other treatments. Simply because the duration
of (antibiotic) treatment is short. When I prescribe an antibiotic, and even if it is an expensive one, then I know
it takes 10 days or 2 weeks, so the treatment is limited from the outset. When I prescribe someone a drug for
high blood pressure, which in the quarter costs 150V, then I am affected each quarter. Thus, the
antibioticsdtreatment when it comes to price, is certainly not as problematic as the high blood pressure
treatment or other therapies I am prescribing. (2-1)
Other
non-patient
determinants
We have experienced changes: like short stays in hospital. Hospitals are simply the most dangerous places
for patients. The sooner the patient is out of the hospital the better. The more minimal invasive interventions
are, the lower the probability for wound infections. (3-7)
Recent medical interventions are indeed more complex and daring; cardio-haematology, oncology. We are
also treating acute myelogenous leukaemia, which accounts for a lot of consumption of antibiotics. You also
can’t ignore that in certain areas treatments are simply too complex. The result is also that inappropriate
consumption is higher. This is the price for medical progress. Bypasses for 80 year olds, do an ACVB and then
they still catch pneumonia, lie for weeks in intensive care. This is the reality now. We believe in all sorts of
advances; but we’ll see the resulting effects soon enough. (4-1)
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Physicians’ views on antibiotic prescribing and resistance“I think the development of resistance is more the
domain of clinical treatment and not the patient.” (2-5)
“Exactly.” (2-3)
“Yeah, especially in intensive care.” (2-4)
Participants discussed most frequently that patient
demand (11) is a major driver for prescribing in the
outpatient setting, followed by doctor experience (9)
and speciﬁc diagnoses (6). The role of the patient,
including patient non-compliance and self-medication,
also emerged. Physicians discussed two types of patients:
those concerned with getting an antibiotic and those
concerned with avoiding what they think is harmful:
“Pressure from patients is not insigniﬁcant.the worst are
the mothers where the children are really very sick and the
mothers say: I don’t want any chemotherapy. The lymph
nodes are thick with pus, almost hanging out, and then
the mother says no, no antibiotics for us. That’s bad.” (2-1)
Physicians in this group valued information that is
concise and available to them in a way that complements
their work without taking up too much time:
“Is there a new antibiotic? What is the resistance situa-
tion? Which organisms are being affected? What are the
indications, what are the side effects? The interactions
with other drugs? Are there alternatives? If this informa-
tion could be given to us in a short and sweet way, then we
would be happy. Something like this is not currently
available to us.” (2-1)
Participants in focus group 2 found treatment guide-
lines (8), pharmaceutical-based materials (5) and
conferences (4) to be main sources of information
on antibiotics. This group found information from
pharmaceuticals to be concise and readily available:
“There’s been a big change from the expertise of repre-
sentatives who come in. These are all clinicians and they
do not give a bad impression at all. They bring me a lot of
information although, of course, you have to make sense
of it all. But I do admit that I feel as though I am getting
good consulting. Because I don’t have the time to do
my own research nor to sit down on the Internet
every evening. I am very grateful for the very speciﬁc
information they offer me.” (2-2)
As evidenced above, most other comments about the
pharmaceutical industry also remained positive in this
group. There were comments that patient outreach is
not needed in Germany (2), and this focused largely on
the belief that the patient population is well informed
and, if at all, opposed to antibiotics, sometimes opting
for alternative therapies.
They discussed the need to have more access to
surveillance of their local resistance situation: “I think we
need what there was in (the former) East Germany,
a short, independent information sheet that shows the
current epidemiological situation in the country or the
region where I live.” (2-5) The group seems to have
agreed since they mostly discussed interest the following
intervention options: increased surveillance (9),
including information on their regional resistance situ-
ation (5), constraints on their patient consult time (3)
and consulting (2).
Focus group 3: hospital physicians with fewer years of
experience
Physicians most frequently discussed their general
impressions on rising resistance (70), hospital-speciﬁc
inﬂuences on prescribing (40), sources of information
on antibiotics (15) and physician-oriented interventions
(12). Patient non-compliance (8), correct prescribing
and antibiotic dosing (5), hospital care (3) and hygiene
(3) were the most frequently addressed topics.
The internet (3), pharmaceutical advertising (2) and
conferences (2) were listed as the most frequent physi-
cian-oriented interventions mentioned by this group.
The visibility of pharmaceutical advertising was also
discussed, and this group found it easy to access and
useful for learning. Participants were in agreement
about how pharmaceutical advertising is more accessible
than other traditional forms of information dissemina-
tion, such as medical journals.
Participants overwhelmingly stayed with the topic of
hospital workplace concerns, like hygiene (7) and time
for patient consult (4) as the most needed intervention
to combat resistance in their setting. They discussed
non-structural demands on the hospital, such as
advances in treatment possibilities for more complex
indications, which might necessitate more antibiotics
consumption in the hospital setting, which may in turn
itself be a driver for resistance.
The hospital itself was viewed as having structural
aspects that might contribute to increased antibiotic use
and resistance (7). One such aspect, maintaining
hygiene, was a perceived danger of interrelated issues of
increased patient load (3), patientepatient contact (1)
and infectiousness (2). One physician noted that the
pressure to treat more patients has led to a related need
for a faster consult time, which may put strain on the
thoroughness of hospital hygiene measures. Hospital
physicians also pointed out that they would prefer to
pursue intervention through new programmes for
hygiene, although they also recognise it to be a chal-
lenging method of improvement. Participants also
discussed the beneﬁts of transparency and feedback on
antibiotic consumption, costs and trends in the hospital
setting.
Focus group 4: hospital physicians with more years of
experience
Participants discussed most frequently about their
general impressions on rising resistance (66), followed
by hospital-speciﬁc inﬂuences on prescribing (29),
sources of information on antibiotics (27) and physician-
oriented interventions (21). The most frequent topics
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Physicians’ views on antibiotic prescribing and resistancebrought up by this group were diagnostics possibilities
(5), patient history/epidemiology (increasingly acute
cases in care) (4) and social factors like ageing (4).
When talking about the inﬂuence on prescribing in
hospital care, the following topics were most frequent:
indication and disease (2), risk assessment in acute cases
(2), speciﬁcity of guidelines (2) and time constraints
during patient consultation (2). This group of physicians
made relatively long commentaries at a higher level of
detail than was observed in participants during the other
focus group sessions. The group spoke at such detail
about non-patient factors of antibiotic prescribing and
antibiotic resistance, including patient stays in non-
intensive wards of hospitals as increasing risk and mini-
mised hygiene routines in hospital due to increased
patient intake.
Physicians frequently consulted specialty journals (9),
clinical handbooks (3) and the internet (3) as sources of
information on antibiotics. Discussion points on hospital
feedback on the resistance situation (5) and continuing
education (2), especially in the area of hygiene (2) and
infectious diseases (2) emerged most frequently in
discussions regarding intervention for antibiotic
resistance.
Collegial exchange with microbiologists/laboratories
(5) emerged as the most frequent topic under the
category of hospital-speciﬁc inﬂuences on prescribing,
something that was also observed in focus group 3.
Physicians in this group spoke about opportunities to
closely collaborate with laboratories and microbiologists,
which they saw as helpful in navigating antibiotic
treatments:
The microbiologists that we have are top. We mostly get
reports via the doctor calling us before anything is
published on our intranet. It is then also discussed, what
underlying disease does the patient have, which antibiotic
was given, and the provisional ﬁndings will be commu-
nicated ﬁrst. Short, quick ways; you have to communicate
well with people. (4-1)
The topic of outsourcing of laboratories arose
throughout this discussion. Physicians perceived this as
prohibiting close communication and producing too
much bureaucracy, “For us, it is unfortunately not the
case. The laboratory has been outsourced. A service
provider is at the other end of town; they can’t
communicate with us much.” (4-5) Other emerging
themes were the role of the hospital pharmacist in
inﬂuencing prescribing choices (4), followed by how
often and appropriately internal/hospital antibiotic
treatment guidelines are updated (4) and subsequently
by multi-resistant pathogens (3).
DISCUSSION
Past research has underlined the importance of patient-
oriented factors of inﬂuence for prescribing, and the
focus has primarily been on patient demand and non-
compliance.
15e17 This is consistent with the historical
data on the subject showing that antibiotics are more
likely to be prescribed when the patient expects them
and that they may be even more likely to be prescribed
when the doctor may perceive that the patient wants
a prescription, when in fact the demands of patient are
unclear.
18 Responses from physicians in these groups
indicated something different: an overwhelming interest
in non-patient factors that inﬂuence antibiotic
prescribing and resistance.
A major topic in both groups of participating physi-
cians from outpatient care was their experience of
increasingly difﬁcult diagnoses that are complicated by
resistance patterns. A good example is the increasing
prevalence of antibiotic-resistant UTIs. Many partici-
pants are involved in the management of UTIs, a ﬁnding
supported by the cross-sectional study component of this
research (survey).
9 Indeed, the trends in many Euro-
pean studies of antimicrobial resistance show UTIs to be
accountable for a large amount of antibiotics consump-
tion.
1 Many of the common pathogens leading to UTIs,
such as Escherichia coli, Proteus mirabilis and Klebsiella
pneumoniae, are increasingly becoming resistant to stan-
dard treatments, which affects antibiotic treatment
choices
19 20; however, physicians showed differential
interest topics related to their antibiotics prescribing and
resistance, based on their care setting.
Outpatient care physicians found resistance primarily
a problem of the hospital care setting, related to the
presence of different multi-resistant pathogens and
challenges with hygiene. This was also a major topic
discussed by hospital physicians. The increasing preva-
lence of multiresistant pathogens is of particular
concern, especially given the views that the hospital ward
is increasingly faced with more patients at any single
time and that patientsdmany of whom are carrying
more complex indicationsdare also seen during shorter
consult times.
21 22 In fact, data from the survey identiﬁed
that status as a hospital physician was a predictor for
deciding to start antimicrobial therapy on a patient.
9
This could be attributed to the fact that, generally,
hospital physicians attend more acute cases than their
outpatient care counterparts.
Hospital care physicians were accustomed to regular
and easy collaboration with microbiologists when
discussing indications and possibilities for therapy. This
was also found in the study sample of the survey, which
showed that hospital physicians found it either impor-
tant or very important that they receive data on regional
antimicrobial resistance and appropriate feedback for
prescribing.
9 This opinion was also shared in the focus
group discussions among physicians, who want labora-
tories to provide feedback on the resistance situation for
their hospitals. Participants expressed frustration and
concern around outsourcing of laboratories. It was
a matter of having less contact with helpful microbiolo-
gists and described a need: that even in a hospital setting
with outsourced laboratory services, it is important to
offer chances to dialogue with microbiologists. While
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national survey, more qualitative research on other
groups could help to show whether or not there is
a need to enhance access to their local resistance situa-
tion in the hospital setting in other areas of Germany.
There was differential discussion about treatment
guidelines, which may also be an important inﬂuence
factor on physician prescribing practice. Participants
from the outpatient care setting found clinical recom-
mendations to be difﬁcult to access quickly and use. For
the hospital setting, this was signiﬁcantly different.
There was more discussion about whether guidelines are
up to date and about their relevance, speciﬁcity and
availability in clinical practice. There are many guide-
lines with varying degrees of quality available to physi-
cians. Hospital care physicians have an array of inhouse
developed guidelines, differentially taking into account
local resistance data.
23 But, as also evidenced by other
studies, availability is differential and may warrant
addressing this separately for each practice setting.
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The pharmaceutical industry was often a major topic of
discussion, but it remains unclear how large the current
inﬂuence of the pharmaceutical industry is on physicians
in Germany. Physicians indicated that the pharmaceu-
tical industry plays a large role in outpatient care prac-
tice. Visits to doctors’ ofﬁces by the industry and free
samples of antibiotics are ubiquitous; their informational
materials are generally perceived as attractive. This may
have to do with the fact that information from the
industry presents information in ways that are more
convenient than scientiﬁc literature on the same
topics.
25 These important ﬁndings about the presence of
the pharmaceutical industry also showed up among the
participants of the survey: despite some caution about
the persistence of the industry, most outpatient care
physicians welcome their assistance and view them as
another resource among many other sources of infor-
mation on antibiotics. Results from these focus groups
and the survey indicate that the pharmaceutical industry
has a large presence among physicians in Germany.
CONCLUSIONS
Our ﬁndings suggest that physicians in Berlin are inter-
ested in topics around their own prescribing, like
physician sensitivity to patient need, time management
for patient consult, access to guidelines and their
perception of the pharmaceutical industry. These non-
patient determinants, when coupled with intervention
ideas for the hospital care setting (eg, improving hygiene
measures, easing diagnostics and cooperation with
laboratories), are different from factors of antibiotic
prescribing and resistance that have been previously
observed in similar contexts: they are physician oriented.
Furthermore, focus group discussions provided more
details about some of the determinants that were also
found relevant by physicians participating in the survey
component of this research. Together, these study
components raise questions about whether targeting
other physicians may be a better approach for inter-
vention that aims to inﬂuence antibiotic resistance in
this and other areas of Germany. This could be
a remarkable ﬁnding for Germany: in other countries,
intervention to reduce antimicrobial resistance has often
been targeted at the patient directly, but more qualita-
tive research and similar focus groups in other areas of
Germany could show whether or not this trend is
nationally relevant.
STUDY LIMITATIONS
Participants were all from the Berlin region and
included physicians from diverse backgrounds with
respect to age, sex, size of practice, care setting and
number of years in practice. Additionally, we recruited
physicians from the former east and west areas of Berlin
and from outer city areas to reﬂect greater diversity
speciﬁc to this setting in Germany. We used a relatively
small, purposive convenience sample of physicians from
specialties known to prescribe most often; thus, there
may have been some degree of representational
bias. Although many ﬁndings from the focus groups
align well with ﬁndings from our nationally representa-
tive survey, which was conducted to further explore
inﬂuence factors on this topic, other focus groups in
other regions or large metropolitan areas in Germany
could strengthen these results and are critical before
determining national relevance.
The same moderator conducted all focus group
discussions based on a conceptual framework drawn
before the sessions, so there could be issues of reliability
due to its application to four different groups of physi-
cians. But, since we intended for the moderator to allow
for participants in each group to explore topics differ-
entially around this framework, so that any new or
previously unanticipated topics could come up, we
believe that this provided a strength that is unique to this
qualitative approach.
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